Literature DB >> 3277274

The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.

A S Fauci1.   

Abstract

Infection with the human immunodeficiency virus (HIV) results in a profound immunosuppression due predominantly to a selective depletion of helper/inducer T lymphocytes that express the receptor for the virus (the CD4 molecule). HIV also has tropism for the brain leading to neuropsychiatric abnormalities. Besides inducing cell death, HIV can interfere with T4 cell function by various mechanisms. The monocyte serves as a reservoir for HIV and is relatively refractory to its cytopathic effects. HIV can exist in a latent or chronic form which can be converted to a productive infection by a variety of inductive signals.

Entities:  

Mesh:

Year:  1988        PMID: 3277274     DOI: 10.1126/science.3277274

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  347 in total

1.  Segmental analysis of molecular surface electrostatic potentials: application to enzyme inhibition.

Authors:  Tore Brinck; Ping Jin; Yuguang Ma; Jane S Murray; Peter Politzer
Journal:  J Mol Model       Date:  2003-02-21       Impact factor: 1.810

2.  Immunological markers of disease progression in patients infected with the human immunodeficiency virus.

Authors:  J M Pascale; M D Isaacs; P Contreras; B Gomez; L Lozano; E Austin; M C De Martin; R L Gregory; G L McLaughlin; A Amador
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

3.  Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus.

Authors:  B Etemad-Moghadam; D Rhone; T Steenbeke; Y Sun; J Manola; R Gelman; J W Fanton; P Racz; K Tenner-Racz; M K Axthelm; N L Letvin; J Sodroski
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

4.  Analytic results for quantifying HIV infectivity.

Authors:  J L Spouge; S P Layne; M Dembo
Journal:  Bull Math Biol       Date:  1989       Impact factor: 1.758

5.  Functional analysis of the Tat trans activator of human immunodeficiency virus type 2.

Authors:  R Fenrick; M H Malim; J Hauber; S Y Le; J Maizel; B R Cullen
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

6.  Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody.

Authors:  P Gupta; R Balachandran; M Ho; A Enrico; C Rinaldo
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

7.  The vpu protein of human immunodeficiency virus type 1 plays a protective role against virus-induced apoptosis in primary CD4(+) T lymphocytes.

Authors:  Satoshi Komoto; Shoutaro Tsuji; Madiha S Ibrahim; Yong-Gang Li; Jiranan Warachit; Koki Taniguchi; Kazuyoshi Ikuta
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Cycling memory CD4+ T cells in HIV disease have a diverse T cell receptor repertoire and a phenotype consistent with bystander activation.

Authors:  Wei Jiang; Souheil-Antoine Younes; Nicholas T Funderburg; Joseph C Mudd; Enrique Espinosa; Miles P Davenport; Denise C Babineau; Scott F Sieg; Michael M Lederman
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

9.  Identification of cellular proteins that bind to the human immunodeficiency virus type 1 trans-activation-responsive TAR element RNA.

Authors:  A Gatignol; A Kumar; A Rabson; K T Jeang
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

10.  Declining incidence of AIDS dementia complex after introduction of zidovudine treatment.

Authors:  P Portegies; J de Gans; J M Lange; M M Derix; H Speelman; M Bakker; S A Danner; J Goudsmit
Journal:  BMJ       Date:  1989-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.